RPMI 1640

Originally designed for the growth of human leukemic cells in monolayer or suspension cultures using a serum supplement, it has since demonstrated universal use in the growth and support of a broad spectrum of mammalian and hybrid cells as well as in hybridoma fusion protocols.

Finally, to find out more and discuss your specific needs please contact sales@lifesciencegroup.co.uk or call +44 (0) 1234 889180

RPMI 1640